| 22-May-13 01:33PM | Profiting From BARDA Contract Awards at Seeking Alpha |
| 08:00AM | Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference PR Newswire |
| 17-May-13 01:04PM | CLEVELAND BIOLABS INC Financials EDGAR Online Financials |
| 14-May-13 08:10PM | 4 Healthcare Stock Stories For Tuesday Investment Wellness at Wall St. Cheat Sheet |
| 08:05AM | InPlay: Cleveland Biolabs and Incuron announce US and European patent allowances for curaxins Briefing.com |
| 07:30AM | Cleveland BioLabs and Incuron Announce US and European Patent Allowances for Curaxins GlobeNewswire |
| 09-May-13 05:11PM | Cleveland BioLabs' CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha -6.04% |
| 09:13AM | CORRECTION -- Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development Progress GlobeNewswire |
| 07:30AM | Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development Progress GlobeNewswire |
| 07:07AM | Q1 2013 CLEVELAND BIOLABS INC Earnings Release - Before Market Open CCBN |
| 12:40AM | CLEVELAND BIOLABS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princ EDGAR Online |
| 08-May-13 07:30AM | Cleveland BioLabs Announces Appointment of Shareholder Representative to Board GlobeNewswire |
| 07-May-13 05:16PM | Isis Initiates ISIS-STAT3 Study Zacks |
| 06-May-13 07:16AM | Zacks Bull and Bear of the Day Highlights: Private Bancorp, Pan American Silver, AVEO Pharmaceuticals, Astellas Pharma and Cleveland BioLabs Zacks |
| 03-May-13 04:30PM | Negative Opinion on AVEO/ALPMY Candidate Zacks |
| 04:00PM | Loss at Aegerion Narrower Than Expected Zacks |
| 01-May-13 08:22AM | Vertex Loss Lower, Kalydeco Outlook Up Zacks -6.18% |
| 07:02AM | InPlay: Cleveland Biolabs, Roswell Park announce publication of studies defining role of liver in activity of Entolimod; results showed that the liver is a major primary target organ of Entolimod Briefing.com |
| 07:00AM | Cleveland BioLabs, Roswell Park Announce Publication of Studies Defining Role of Liver in Activity of Entolimod (CBLB502) GlobeNewswire |
| 30-Apr-13 03:20PM | Double Setback for Gilead Zacks |
| 02:30PM | Merck - Pfizer in Diabetes Deal Zacks |
| 07:56AM | Cleveland BioLabs to Report First Quarter 2013 Financial Results and Provide Operational Update on May 9 GlobeNewswire |
| 29-Apr-13 04:10PM | CHMP in Favor of Celgene's Revlimid Zacks |
| 09:20AM | Geron Narrows Loss; Cuts Jobs Zacks |
| 26-Apr-13 04:00PM | Earnings Increase at The Medicines Co. Zacks |
| 25-Apr-13 11:15AM | Celgene Earnings Rise Y/Y Zacks |
| 11:00AM | Biogen's Earnings Surpass Expectations Zacks |
| 06:41AM | CLEVELAND BIOLABS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 24-Apr-13 04:40PM | Isis Pharma's ISIS-SMNRx Progresses Zacks |
| 12:15PM | Tax Benefit Boosts Amgen Earnings Zacks |
| 23-Apr-13 05:40PM | Merck - BMY in HCV Deal Zacks |
| 09:31AM | Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks at Seeking Alpha |
| 07:02AM | InPlay: Cleveland Biolabs appoints Julia Brown and Anthony Principi as new independent directors and David Hohn, a current director, as Chairman of the board Briefing.com |
| 07:00AM | Cleveland BioLabs Announces Changes to Board of Directors GlobeNewswire |
| 22-Apr-13 05:20PM | Merck In-Licenses from Xenon Zacks +5.38% |
| 17-Apr-13 04:16PM | Achillion's HCV Candidates Progress Zacks |
| 16-Apr-13 06:10PM | Actelion Beats Earnings, Sales Rise Zacks |
| 15-Apr-13 01:20PM | Affymetrix Down to Underperform Zacks -5.97% |
| 12-Apr-13 04:10PM | Repros Gets Additional Patents Zacks |
| 11-Apr-13 04:40PM | Alkermes Announces Restructuring Plan Zacks |
| 10-Apr-13 05:25PM | ADC Data from Seattle Genetics Zacks |
| 08:10AM | Affymetrix to Disappoint in 1Q Zacks |
| 09-Apr-13 04:41AM | CLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principa EDGAR Online +5.88% |
| 08-Apr-13 05:45PM | Illumina Introduces TruSight Tumor Zacks |
| 10:54AM | Cleveland BioLabs appoints Jean Viallet to Chief Development Officer theflyonthewall.com |
| 10:53AM | Cleveland BioLabs Strengthens Clinical Development Team GlobeNewswire |
| 04-Apr-13 04:12PM | Positive Data on Repros' Androxal Zacks |
| 02-Apr-13 02:18PM | 4 Healthcare Stock Stories for Tuesday Investment Wellness at Wall St. Cheat Sheet |
| 07:03AM | InPlay: Cleveland Biolabs announced the receipt of a Notice of Allowance from the FDA for an Investigational New Drug application for CBL0137. Briefing.com |
| 07:00AM | Cleveland BioLabs and Incuron Announce Notice of Allowance From FDA to Commence Clinical Testing With CBL0137 GlobeNewswire |
| 28-Mar-13 01:18PM | Affymetrix Inks Deal with UK Biobank Zacks |
| 22-Mar-13 01:04PM | CLEVELAND BIOLABS INC Financials EDGAR Online Financials +9.74% |
| 10:04AM | On The Fly: Analyst Initiation Summary theflyonthewall.com |
| 21-Mar-13 02:36PM | GenCorp Gets a Thumbs Up and 4 More Analyst Notes to Read Now at Wall St. Cheat Sheet +8.94% |
| 01:26PM | 5 Stocks Under $10 Triggering Breakouts at TheStreet |
| 10:06AM | On The Fly: Analyst Initiation Summary theflyonthewall.com |
| 08:18AM | Zacks #1 Rank Additions for Thursday Zacks |
| 20-Mar-13 09:48PM | Coverage initiated on Cleveland Biolabs by Cantor Fitzgerald Briefing.com |
| 06:57PM | On The Fly: After Hours Movers at theflyonthewall.com |
| 19-Mar-13 03:31PM | A $2.8 Billion Opportunity With All-Hazards Program: Will Cleveland Biolabs Get A Slice? at Seeking Alpha |
| 18-Mar-13 10:17AM | CLEVELAND BIOLABS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 16-Mar-13 07:33PM | New Star Analyst Rankings for Cleveland BioLabs, Inc. StarMine |
| 15-Mar-13 07:42PM | New Star Analyst Rankings for Cleveland BioLabs, Inc. StarMine +8.61% |
| 14-Mar-13 04:27PM | Cleveland BioLabs' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha -5.63% |
| 09:10AM | CLEVELAND BIOLABS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online |
| 07:07AM | Q4 2012 CLEVELAND BIOLABS INC Earnings Release - Before Market Open CCBN |
| 07:00AM | Cleveland BioLabs Reports Fourth Quarter and Fiscal 2012 Financial Results and Development Progress GlobeNewswire |
| 08-Mar-13 09:43AM | Cleveland BioLabs to Report Fiscal 2012 Financial Results and Provide Operational Update on March 14 GlobeNewswire |
| 27-Feb-13 09:40AM | Acute Radiation Syndrome, Are We Prepared And Who Is Best Preparing Us? at Seeking Alpha |
| 14-Feb-13 03:20PM | North Korea Tests A Nuke And This Anti-Radiation Stock Is Down? at Seeking Alpha |
| 05-Feb-13 08:20AM | Number of FDA Drug Approvals Reach a 15-Year High in 2012 Marketwire |
| 07:00AM | Cleveland BioLabs to Present at 15th Annual BIO CEO and Investor Conference GlobeNewswire |
| 04-Feb-13 10:24AM | Can Cleveland BioLabs Fight Radiation With This New Drug? at Seeking Alpha +12.58% |
| 31-Jan-13 10:48AM | 4 Speculative Biotech Stocks To Consider at Seeking Alpha |
| 24-Jan-13 07:00AM | Cleveland BioLabs to Present at BARDA and NIAID Sponsored Symposium on Development of Radiation Medical Countermeasures GlobeNewswire |
| 07-Dec-12 10:05AM | On The Fly: Analyst Initiation Summary theflyonthewall.com |
| 06-Dec-12 01:16PM | Crocs Initiated at Outperform and 1 Initiated Stock on the Move at Wall St. Cheat Sheet +6.43% |
| 01:10PM | 5 Under-$10 Charts Showing Major Upside at TheStreet |
| 10:09AM | On The Fly: Analyst Initiation Summary theflyonthewall.com |
| 05-Dec-12 11:15PM | Coverage initiated on Cleveland Biolabs by Oppenheimer Briefing.com |
| 04-Dec-12 01:39PM | Imperva Initiated at Outperform and 3 Must-See Initiated Stocks at Wall St. Cheat Sheet |
| 07:00AM | Cleveland BioLabs to Present at Oppenheimer 23rd Annual Healthcare Conference GlobeNewswire |
| 03-Dec-12 11:21PM | Coverage initiated on Cleveland Biolabs by Burrill Institutional Research Briefing.com |
| 27-Nov-12 07:02AM | InPlay: Cleveland Biolabs, a subsidiary of Cleveland BioLabs, signs contract for ~$4.6 mln with Russian Ministry of Industry and Trade for Development of Xenomycins Briefing.com |
| 07:00AM | Panacela Labs, a Subsidiary of Cleveland BioLabs, Signs Contract for Approximately $4.6 Million With Russian Ministry of Industry and Trade for Development of Xenomycins GlobeNewswire |
| 16-Nov-12 01:04PM | CLEVELAND BIOLABS INC Financials EDGAR Online Financials |
| 09-Nov-12 04:33PM | CLEVELAND BIOLABS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08-Nov-12 10:19PM | Cleveland BioLabs' CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 07:15AM | CLEVELAND BIOLABS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online |
| 07:07AM | Q3 2012 CLEVELAND BIOLABS INC Earnings Release - Before Market Open CCBN |
| 07:00AM | Cleveland BioLabs Reports Third Quarter 2012 Financial Results and Development Progress GlobeNewswire |
| 06-Nov-12 07:00AM | Cleveland BioLabs Announces Publication of Studies on Effect of Entolimod(TM) (CBLB502) on Graft-Versus-Tumor Activity in Models of Allogeneic Bone Marrow Transplantation GlobeNewswire |
| 30-Oct-12 07:00AM | Cleveland BioLabs to Report Third Quarter Financial Results and Provide Operational Update on November 8 GlobeNewswire |
| 25-Oct-12 07:02AM | Department of Defense Chemical Biological and Medical Systems Continues Funding Under Development Contract With Cleveland BioLabs for Entolimod(TM) (CBLB502) GlobeNewswire |
| 23-Oct-12 02:29PM | Cleveland Biolabs: Gunning For $50 Million In Government Funding at Seeking Alpha -6.67% |
| 22-Oct-12 06:01AM | CLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme EDGAR Online |
| 19-Oct-12 11:42AM | Health Care Plunge: 4 Stocks Falling Hard at Motley Fool -26.21% |
| 09:41AM | Cleveland BioLabs shares plummet after stock offer AP |
| 09:02AM | InPlay: Cleveland Biolabs priced offering of 7.5 mln units at $2.00 per unit Briefing.com |
| 09:01AM | Cleveland BioLabs Prices $15 Million Public Offering of Common Stock and Warrants GlobeNewswire |